Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,403 INR | +0.22% | -4.14% | +17.63% |
03-18 | Rainbow Children's Medicare Limited Approves Appointment of Adarsh Kancharla as Non-Executive Director | CI |
03-08 | Rainbow Children's Medicare Expands Capacity of Hyderabad, India Hospital | MT |
Summary
- The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 61% by 2026.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With an expected P/E ratio at 63.15 and 51.91 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+17.63% | 1.71B | C- | ||
-18.90% | 16.51B | B+ | ||
+4.50% | 12.53B | B | ||
+4.81% | 11.74B | B+ | ||
+2.43% | 10.06B | B+ | ||
+29.69% | 8.71B | B | ||
-4.75% | 7.57B | A- | ||
+19.68% | 7.22B | D | ||
+5.46% | 6.68B | B- | ||
-2.79% | 4.32B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- RAINBOW Stock
- Ratings Rainbow Children's Medicare Limited